背景:由法国呼吸疾病学会COPD工作组组织的第二届COPD双年展于2023年12月13日在巴黎(Cochin)举行。
背景:讨论了2023年的主要趋势;它们涵盖了概念,定义,生物制剂,护理途径,肺部康复和呼吸道感染带来的复杂情况,心血管合并症和肺动脉高压,以及氧疗和通气的方式。
结论:不同的讨论强调了COPD的主要变化,包括COPD前期的概念,病因,健康轨迹和恶化的新定义。COPD生物制剂的最新结果为新的药理学选择打开了大门。对法国当前护理途径的评估强调了一些令人担忧的原因。例如,肺康复是一个关键但实践不足的因素。呼吸道感染需要仔细评估和治疗。心血管合并症和肺动脉高压的诊断和治疗至关重要。截至最近,氧气疗法和通气方式已经发展起来,并开始提供更多个性化选择。
结论:关于COPD,个性化的方法至关重要,将患者置于护理路径的中心,并促进医疗保健提供者之间的协调。
BACKGROUND: The second COPD Biennial organized by the COPD working group of the French Society of Respiratory Diseases took place in Paris (Cochin) on 13th December 2023.
BACKGROUND: Major trends in 2023 were discussed; they encompassed concepts, definitions, biologics, care pathways, pulmonary rehabilitation and complex situations entailed by respiratory infections, cardiovascular comorbidities and pulmonary hypertension, and modalities of oxygen therapy and ventilation.
CONCLUSIONS: The different talks underlined major changes in COPD including the concepts of pre-COPD, etiotypes, health trajectories and new definitions of exacerbation. Recent results in biologics for COPD open the door to new pharmacological options. Assessment of current care pathways in France highlighted some causes for concern. For example, pulmonary rehabilitation is a key but insufficiently practiced element. Respiratory infections require careful assessment and treatments. Diagnosis and treatment of cardiovascular comorbidities and pulmonary hypertension are of paramount importance. As of late, oxygen therapy and ventilation modalities have evolved, and are beginning to afford more personalized options.
CONCLUSIONS: As regards COPD, a personalized approach is crucial, placing the patient at the center of the care pathway and facilitating coordination between healthcare providers.